mifepristone has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daly, M; Farrow, S; Ray, KP; Searle, N; Talabot, F | 1 |
| Kankaanranta, H; Moilanen, E; Zhang, X | 2 |
3 other study(ies) available for mifepristone and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids.
Topics: Androstadienes; Beclomethasone; Dexamethasone; Dose-Response Relationship, Drug; E-Selectin; Endothelium, Vascular; Fluticasone; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; Humans; Interleukin-1; Mifepristone; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Receptors, Glucocorticoid; Transcriptional Activation; Tumor Necrosis Factor-alpha | 1997 |
Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone.
Topics: Androstadienes; Anti-Asthmatic Agents; Apoptosis; Beclomethasone; Budesonide; Dose-Response Relationship, Drug; Eosinophils; Fluticasone; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-5; Mifepristone; Tumor Necrosis Factor-alpha | 2000 |
Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis.
Topics: Androstadienes; Anti-Inflammatory Agents; Apoptosis; Beclomethasone; Budesonide; Cells, Cultured; Down-Regulation; Fluticasone; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Mifepristone; Neutrophils; Receptors, Glucocorticoid | 2001 |